| |
| 1. Foreign LP¡¯s ¨C Discussion of Global and China¡¯s Asset Allocation Strategies |
| • How should LPs readjust their global asset allocation strategies amid the world¡¯s economic recovery? |
• How should foreign LPs develop their China-focused investment strategies?
What sort of opportunities and risks exist in China¡¯s PE market?
How should foreign LPs identify and evaluate Chinese funds¡¯ investment opportunities?
What are the benefits and risks for investing in franchise name-brand funds? |
• How should foreign LPs select access routes to China¡¯s LP investment market?
And how should foreign LPs partner with their Chinese peers? |
| • How can the evolution and development of overseas PE markets enlighten the growing China¡¯s PE market? |
| |
| 2. Chinese LP¡¯s ¨C Fostering a Mature LP Investment Market |
| • Review of China¡¯s LP industrial history |
• What is the right roadmap for China¡¯s developing LP market?
How should Chinese LPs build and expand their institutional investor base? |
| • How should Chinese LPs evaluate the development and existing regulatory regime of China¡¯s PE industry? |
| • What should Chinese LPs learn from the development experience of overseas markets? |
| |
| 3. Fund of Funds (¡°FOFs¡±) |
| • FOFs¡¯ Added Value |
| • Portfolio Structuring: Diversification & Liquidity Management |
| • Real-World GP Selection: Evaluating fund performance & identifying outstanding management teams |
• Trends: China-focused FOFs & RMB-denominated FOFs?
What is the financial/operational viability for RMB-denominated FOFs? |
| |
| 4. Coordinating GP/LP Relations ¨C How to achieve a Win-win situation |
| • How to foster and handle LP/GP relations within the domestic context? |
| • Life cycle of GP/LP relations |
| • Improved Transparency & Communication Mechanism |
| • How can foreign management teams align conflicting interests during capital-raising for RMB funds? |
• From GP Perspective?How should GPs optimize their fundraising strategies and
manage the pace of their fundraising in response to extending fundraising cycles?
How should GPs screen for qualified LPs? |
| • J-Curve Effect s & The Need for LPs to be Patient |
| • From GP Perspective: How to Select Qualified LPs |
| |